Poland's industry association elects new management
This article was originally published in Scrip
Executive Summary
Poland's association of research-based companies, Infarma, has elected a new management board for a two-year term. Jerzy Toczyski of GlaxoSmithKline has become its president and Peter Koetsier of Bristol-Myers Squibb its vice-president. Jaroslaw Lange of Amgen, Marynika Woroszylska-Sapieha of Sanofi-Aventis, Patrick van Ginneken of Pfizer and Lukasz Zybaczynski of MSD were elected board members, while Donald Bellamy of Novartis was appointed Infarma's treasurer.